5JK3
Crystal structure of TL11-128 bound to TAK1-TAB1
5JK3 の概要
エントリーDOI | 10.2210/pdb5jk3/pdb |
分子名称 | Mitogen-activated protein kinase kinase kinase 7,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1, ~{N}-[2-[5-chloranyl-2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide (2 entities in total) |
機能のキーワード | mitogen activated protein kinase kinase kinase 7, tgf-beta activated kinase 1 and map3k7-binding protein 1 chimera, serine/threonine kinase which act as essential component of the map kinase signal transduction pathway, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 35834.66 |
構造登録者 | |
主引用文献 | Tan, L.,Gurbani, D.,Weisberg, E.L.,Hunter, J.C.,Li, L.,Jones, D.S.,Ficarro, S.B.,Mowafy, S.,Tam, C.P.,Rao, S.,Du, G.,Griffin, J.D.,Sorger, P.K.,Marto, J.A.,Westover, K.D.,Gray, N.S. Structure-guided development of covalent TAK1 inhibitors. Bioorg. Med. Chem., 25:838-846, 2017 Cited by PubMed: 28011204DOI: 10.1016/j.bmc.2016.11.035 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.371 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード